Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
WHO gives approval to Novavax-Serum Institute's Covavax Covid vaccine for emergency use
https://www.wionews.com/india-general-elections-2019/who-gives-approval-to-novavax-serum-institutes-covavax-covid-vaccine-for-emergency-use-437737
The World Health Organisation (WHO) on Friday gave emergency approval to Covovax, Serum Institute of India’s version of Novavax Inc`s COVID-19 vaccine.
CEO of the Pune-based world's largest manufacturer Adar Poonawalla hailed the WHO for giving approval for emergency use.
“This is yet another milestone in our fight against COVID-19, Covovax is now W.H.O approved for emergency use, showing excellent safety and efficacy. Thank you all for a great collaboration,” he tweeted.
Covavax—a two-dose vaccine— will also likely be used for children aged above 3 years and it would be launched in mid-2022, Poonawalla had said earlier.
Covovax was assessed under the WHO EUL procedure based on the review of data on quality, safety and efficacy, a risk management plan, programmatic suitability, and manufacturing site inspections carried out by the Drugs Controller General of India.
Novavax’s COVID-19 vaccine had shown 90 per cent efficacy at preventing Covid illness, according to results from a Phase 3 clinical trial.
In addition to being highly effective in preventing Covid illness of any severity, the vaccine was 100 per cent effective in preventing moderate and severe disease that required hospitalisation, revealed the study published in the New England Journal of Medicine.
The World Health Organisation (WHO) on Friday gave emergency approval to Covovax, Serum Institute of India’s version of Novavax Inc`s COVID-19 vaccine.
CEO of the Pune-based world's largest manufacturer Adar Poonawalla hailed the WHO for giving approval for emergency use.
Link to tweet
“This is yet another milestone in our fight against COVID-19, Covovax is now W.H.O approved for emergency use, showing excellent safety and efficacy. Thank you all for a great collaboration,” he tweeted.
Covavax—a two-dose vaccine— will also likely be used for children aged above 3 years and it would be launched in mid-2022, Poonawalla had said earlier.
Covovax was assessed under the WHO EUL procedure based on the review of data on quality, safety and efficacy, a risk management plan, programmatic suitability, and manufacturing site inspections carried out by the Drugs Controller General of India.
Novavax’s COVID-19 vaccine had shown 90 per cent efficacy at preventing Covid illness, according to results from a Phase 3 clinical trial.
In addition to being highly effective in preventing Covid illness of any severity, the vaccine was 100 per cent effective in preventing moderate and severe disease that required hospitalisation, revealed the study published in the New England Journal of Medicine.
Here's another option available to help vaccinate the world soon.
4 replies
= new reply since forum marked as read
= new reply since forum marked as read
